Sidanis Pharma GmbH
Pharmaceutical Wholesale · Hamburg
Sidanis Pharma GmbH is a pharmaceutical wholesaler based in Hamburg, Germany.
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Sidanis Pharma GmbH Address & Contact
Sidanis Pharma GmbH Overview
Sidanis Pharma GmbH was founded in 2001 in Hamburg and has since established itself as a trusted pharmaceutical wholesaler specializing in the procurement and distribution of medicinal products. The company operates as a certified pharmaceutical distributor with a GDP authorization, ensuring that all business operations are conducted in compliance with Good Distribution Practices. Sidanis Pharma serves a variety of customers, including pharmacies, clinics, and other healthcare facilities that rely on reliable access to approved medicines. Through its strategic positioning within the German and European pharmaceutical distribution chain, Sidanis Pharma has established itself as a reliable partner that consistently adheres to high-quality standards.
Services and Field of Activity
Sidanis Pharma GmbH offers a comprehensive range of pharmaceutical products. This includes among others:
- Prescription medicines that are crucial for doctors and pharmacists.
- OTC products (Over-the-Counter), which are available without a prescription and used by the public as important health products.
- Pharmaceutical specialties that are often developed for specific diseases or patient needs.
A central feature of Sidanis Pharma GmbH is the rapid availability and short-term delivery of medicines. The company has established efficient logistics processes and maintains direct relationships with reputable manufacturers as well as other wholesalers. This allows Sidanis Pharma to procure critical shortage products and ensure smooth business operations. GDP-compliant quality assurance is a fundamental element integrated into all company processes. These measures guarantee that the products remain in perfect condition throughout the entire distribution process.
Regulatory Classification
The regulatory classification of Sidanis Pharma GmbH is essential for ensuring product quality and patient safety. As a GDP-certified company, it is subject to strict guidelines that define the requirements for the wholesale of medicinal products. This includes regulations for storage, transportation, and traceability of medicines. Compliance with these standards is regularly monitored, allowing Sidanis Pharma not only to meet legal requirements but also to strengthen customer trust.
Importance for the Region
Sidanis Pharma GmbH plays a significant role in the regional healthcare supply of Hamburg and Northern Germany. Through the fast and reliable supply to pharmacies and other healthcare facilities, the company contributes to the availability of vital medications. The fact that the pharmaceutical wholesaler operates in one of the economically strongest regions of Germany enables efficient organization of even regional deliveries. Furthermore, Sidanis Pharma promotes the local economy by creating jobs and entering into long-term partnerships with other regional companies.
Through continuous investments in logistics and training of employees, Sidanis Pharma ensures that it meets the growing demands of the healthcare market while always responding to the latest developments in the pharmaceutical industry. The willingness to innovate and the commitment to the highest quality standards set Sidanis Pharma GmbH apart from other providers and make it an indispensable player in the region's healthcare sector.
More information: Pharmaceutical wholesale in Hamburg or all pharmaceutical wholesale in Germany on Sanoliste.
Frequently asked questions about Sidanis Pharma GmbH
Was entwickelt Sidanis Pharma?
Sidanis Pharma entwickelt Glykokunjugat-Immunstimulanzien (GCI), eine neue Klasse von Wirkstoffen, die das Immunsystem zur Bekämpfung von Infektionskrankheiten gezielt stimulieren.
Kann Sidanis Pharma Antibiotika ersetzen?
Die von Sidanis Pharma entwickelten GCI-Wirkstoffe sollen als Ergänzung oder Alternative zu Antibiotika und Impfstoffen dienen und so zur Reduzierung von Antibiotikaresistenzen beitragen.
Where is Sidanis Pharma based?
Sidanis Pharma GmbH hat seinen Unternehmenssitz in Hamburg, Deutschland.
More Pharmaceutical Wholesale in Hamburg
Pharmaceutical Wholesale in Germany
Related areas in healthcare
Pharmaceutical Wholesale by location
About Pharmaceutical Wholesale
Pharmaceutical wholesalers (Pharmagrosshandel) form the critical supply chain link between medicine manufacturers and authorised recipients such as pharmacies (Apotheken), hospitals (Krankenhäuser), medical practices and other licensed healthcare facilities. In Germany, the commercial distribution of medicinal products at wholesale level is a strictly regulated, licence-dependent activity. Every pharmaceutical wholesaler must hold a wholesale dealer authorisation (Großhandelserlaubnis) granted under Section 52a of the AMG (German Medicinal Products Act). This authorisation is issued by the pharmaceutical supervisory authority of the relevant German federal state and requires applicants to demonstrate suitable temperature-controlled storage premises, a documented quality management system, a qualified responsible person (verantwortliche Person), and ongoing compliance with the EU Good Distribution Practice (GDP) guidelines. Full-line wholesalers (Vollsortimenter) stock virtually the entire range of authorised medicines available in Germany, whereas specialist wholesalers focus on particular therapeutic areas or logistics requirements such as cold chain products, controlled substances (Betäubungsmittel) or imported parallel-trade medicines. Nationwide, around 15 full-line wholesalers and over 100 specialist wholesalers collectively ensure comprehensive medicine supply to more than 18,000 pharmacies across the country. This directory lists all authorised pharmaceutical wholesalers in Germany holding a valid authorisation under Section 52a AMG, with addresses and full contact details.
The Role of Pharmaceutical Wholesale in Germany's Medicine Supply
Germany's pharmaceutical wholesale sector is the backbone of the country's medicine distribution system, ensuring that more than 18,000 pharmacies and thousands of hospitals receive their medicine supplies reliably, often within hours of ordering. The German wholesale model is built around a hub-and-spoke logistics system: large national full-line wholesalers (Vollsortimenter) operate central and regional warehouses that stock virtually the entire range of authorised medicines. From these warehouses, medicines are delivered to pharmacies typically two or three times per day by refrigerated vans. This high delivery frequency means that pharmacies can operate with lean stock levels while still being able to fill patient prescriptions on the same day. Germany's medicine supply chain performed robustly during the COVID-19 pandemic, demonstrating the resilience of its wholesale infrastructure. The three largest full-line wholesalers in Germany collectively hold a dominant market share, but they compete with each other and with smaller regional and specialist wholesalers.
Legal Requirements Under Section 52a AMG and EU GDP
Operating as a pharmaceutical wholesaler in Germany requires a wholesale dealer authorisation (Großhandelserlaubnis) granted by the competent pharmaceutical supervisory authority of the relevant German federal state under Section 52a of the AMG. This authorisation is not automatic and requires applicants to demonstrate compliance with a detailed set of prerequisites before trading can begin. The premises must be suitable for temperature-controlled storage, with validated temperature mapping studies for all storage areas. A documented quality management system (QMS) must be in place covering procurement, storage, pick and dispatch, complaints, returns, recalls, counterfeiting detection and self-inspections. A qualified responsible person (verantwortliche Person) with the relevant pharmaceutical or scientific qualifications must be designated and approved by the authority. After authorisation is granted, companies must comply with the EU GDP guidelines (EudraLex Volume 5), which are periodically updated. Inspections by the state pharmaceutical authority verify ongoing compliance.
Specialist Wholesale and Cold Chain Logistics in Germany
Beyond full-line wholesale, Germany has a developed specialist wholesale sector catering to specific product categories that require particular expertise or infrastructure. Cold chain wholesale is especially important for biological medicines including monoclonal antibodies, vaccines, insulin and plasma-derived products, which must be stored and transported within defined temperature ranges (typically 2 to 8 degrees Celsius). Controlled substance (Betäubungsmittel) wholesale requires additional authorisation under the Betäubungsmittelgesetz (BtMG) and is subject to strict record-keeping and security requirements. Import wholesale specialises in parallel-imported medicines, sourcing products authorised in other EU member states at lower prices and relabelling them in accordance with German regulatory requirements. Specialty pharmacy wholesale focuses on high-value oncology drugs, immunosuppressants and rare disease treatments. Each of these specialist segments requires specific expertise, infrastructure and additional regulatory permissions beyond the standard Section 52a AMG authorisation.
Medicinal Product Supply Chain Security and Falsification Protection
The integrity of the pharmaceutical supply chain is a central responsibility of pharmaceutical wholesale. Since February 2019, the EU Falsified Medicines Directive (FMD) has been fully in force: every prescription medicinal product pack carries an individual 2D data matrix code, which is scanned and verified at the wholesaler and end recipient in the national verification database (in Germany: securPharm). Temperature-critical products, including biologics, insulins and vaccines, require an unbroken cold chain (2–8 °C or frozen), which the wholesaler ensures with validated cold stores, temperature-controlled transport and temperature monitoring. Controlled substances are additionally subject to the Narcotics Act (BtMG) with strict documentation requirements. Recall management and batch traceability in accordance with GDP guidelines are mandatory. Sanoliste identifies specialist wholesalers for cold chain, controlled substances and parallel import medicines separately.
What does a pharmaceutical wholesaler do?
Pharmaceutical wholesalers procure, store and distribute medicines to pharmacies, hospitals and other authorised recipients. In Germany, wholesale trade in medicines requires authorisation under Section 52a AMG.
What authorisation does a pharmaceutical wholesaler need?
A pharmaceutical wholesaler must hold authorisation under Section 52a of the AMG (German Medicinal Products Act). Requirements include suitable premises, a qualified responsible person and compliance with EU Good Distribution Practice (GDP) guidelines.
How do I find an authorised pharmaceutical wholesaler in Germany?
Authorised pharmaceutical wholesalers are registered with the competent state authority under Section 52a AMG. Sanoliste lists all wholesalers with valid authorisation, including specialisations in cold chain logistics, controlled substances or imported medicines. Filter by federal state for a regional search.
How many pharmaceutical wholesalers are there in Germany?
Germany has approximately 15 full-line pharmaceutical wholesalers (Vollsortimenter) that stock the full range of authorised medicines and deliver to pharmacies nationwide, alongside more than 100 specialist wholesalers focusing on specific therapeutic areas, temperature-sensitive biologics or controlled substances. Together they supply over 18,000 pharmacies across the country.
What does EU Good Distribution Practice (GDP) require?
The EU GDP guidelines (2013/C 343/01) set out requirements for the proper distribution of medicinal products. For pharmaceutical wholesalers this includes maintaining appropriate temperature-controlled storage conditions (especially for cold-chain products), operating a documented quality management system, training qualified personnel, conducting supplier and customer qualification audits, maintaining full traceability records, and having procedures for handling suspected counterfeits, complaints and recalls.
Can a pharmaceutical wholesaler in Germany supply directly to patients?
No. In Germany, pharmaceutical wholesalers are not permitted to supply medicines directly to patients. They may only supply authorised recipients such as pharmacies, hospitals, medical practices (under specific conditions) and other licensed wholesalers. Patients must obtain prescription medicines through a pharmacy, which in turn sources its stock from authorised wholesalers or directly from manufacturers.
What is the difference between a pharmaceutical wholesaler and a medicine broker?
A pharmaceutical wholesaler physically holds medicines in stock, stores them and delivers to authorised recipients such as pharmacies and hospitals. They require a wholesale authorisation under § 52a AMG and must maintain GDP-compliant storage conditions. A medicine broker, by contrast, does not take possession of medicines but merely arranges transactions between manufacturers, wholesalers and buyers. Brokering activities are subject to registration under § 52b AMG.